Streetbeat News

Stock Prices

RLAY

Relay Therapeutics (NASDAQ:RLAY) has been analyzed by 5 analysts, showing a range of sentiments from bullish to somewhat bullish. The average 12-month price target has decreased by 8.93% to $20.4. Analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Despite significant revenue growth, the company faces challenges with ROE and ROA below industry standards.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm

VLO

Valero Energy (NYSE:VLO) has received mixed analyst ratings over the past three months, with a recent trend towards more neutral or slightly bullish outlooks. The average 12-month price target has decreased to $173.23 from $178.31. Analysts have adjusted their ratings and price targets based on evolving market conditions and company performance. Despite a recent revenue decline, Valero maintains strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm

ASB

Analysts' ratings for Associated Banc (NYSE:ASB) over the last quarter show a range of sentiments from bullish to bearish. The average 12-month price target is $23.6, with a high of $27.00 and a low of $22.00. Recent analyst actions include maintaining, lowering, and raising ratings, reflecting their reactions to market conditions and company performance. Associated Banc has faced a 4.2% revenue decline over the past three months and has below-industry benchmarks in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:00 pm

CRBU

In the last three months, 4 analysts have published ratings on Caribou Biosciences (NASDAQ:CRBU), with all ratings being bullish. The average 12-month price target is $15.25, down from a previous average of $19.00. Financial metrics indicate challenges, including a -30.64% revenue decline and a net margin of -1697.57%.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:00 pm

LRHC

La Rosa Holdings Corp. (NASDAQ:LRHC) reported a 15% increase in Q2 transaction volume and a 21% rise in total transaction value, nearly reaching $110 million. The growth is attributed to strategic initiatives and the addition of new agents. The company expects significant year-over-year revenue growth.

Portfolio Pulse from Shivani Kumaresan

July 17, 2024 | 12:00 pm

HMC

MUFG

TKOMY

Honda Motor Co (NYSE:HMC) has priced its secondary share offering at a 3% discount, raising $3.16 billion. Insurers and financial firms, including Tokyo Marine Holdings Inc. (OTC:TKOMY) and Mitsubishi UFJ Financial Group Inc. (NYSE:MUFG), are selling up to 300 million shares. This move follows regulatory pressure to reduce cross-shareholdings.

Portfolio Pulse from Shivani Kumaresan

July 17, 2024 | 11:45 am

USB

U.S. Bancorp shares are trading higher following a Q2 earnings beat.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:43 am

FHN

First Horizon shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:41 am

AMD

ASML

JBHT

NVDA

QQQ

SPY

Nasdaq and S&P 500 futures dropped significantly following weak forecasts from ASML and comments from Donald Trump about Taiwan's defense bill. This has led to a tech sell-off, impacting major ETFs like SPY and QQQ. Several companies, including ASML, Nvidia, AMD, and J.B. Hunt, saw notable premarket movements.

Portfolio Pulse from Shanthi Rexaline

July 17, 2024 | 11:41 am

GTES

Gates Industrial shares are trading higher after it was announced the stock will join the S&P SmallCap 600.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:40 am